There has been substantial progress in the proportion of pregnant persons screened for hepatitis C virus (HCV) infection, but the testing rates are still low, according to an article published online June 9 in Obstetrics ...
Jun 21, 2022
0
3
Hepatitis C virus (HCV) positivity is associated with development of schizophrenia, according to a study recently published in the Journal of Psychiatry & Neuroscience.
Feb 24, 2022
0
20
The hepatitis C virus (HCV) is a genetically highly variable virus that mutates extensively. An effective vaccine would therefore need to evoke broadly neutralizing antibodies that not only neutralize one HCV strain, but ...
Jan 31, 2022
0
5
Hepatitis C virus (HCV) infection can lead to long-term health problems including liver damage, liver failure, cirrhosis, liver cancer and even death. These outcomes are especially dangerous for pregnant people and their ...
Oct 29, 2021
0
30
Pakistan has one of the highest rates of hepatitis C virus (HCV) infection in the world, accounting for over ten percent of global HCV infections. A new modeling study led by the University of Bristol, UK, suggests that achieving ...
Oct 22, 2021
0
13
In a new paper published in Nature, scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, describe the structure of a key protein on the surface of the ...
Sep 21, 2021
0
48
The development of direct-acting antiviral (DAA) agents revolutionized treatment for the hepatitis C virus (HCV) in 2013, changing the disease from one that can be controlled to one that can be cured. But with a list price ...
Sep 6, 2021
0
6
Hepatitis C virus (HCV) may cause chronic infection to the liver, which can result in irreversible liver damage and liver cancer. How HCV manages to evade the immune system to infect the host chronically is not entirely understood. ...
May 24, 2021
0
20
(HealthDay)—The COVID-19 pandemic reduced routine hepatitis C virus (HCV) testing and treatment, according to a study published online May 10 in the American Journal of Preventive Medicine.
May 18, 2021
0
2
Remdesivir is currently the only antiviral drug approved in the U.S. for treating COVID-19 patients. In a paper published this week in Cell Reports, researchers from The University of Texas at Austin, Rensselaer Polytechnic ...
Apr 27, 2021
0
196
